U.S. Markets open in 5 hrs 50 mins

Activist Raging Capital Sizes Up Tidewater

Prescience Point Capital Management cut its holding of the regenerative biomaterials maker to 7,618,335 shares on April 29 through May 3. During that span, Prescience acquired 250,000 shares for $2.31 to $2.51 each and sold 603,925 at prices ranging from $2.44 to $2.53 apiece. Prescience now owns nearly 7% of MiMedx’s outstanding stock.